Press Coverage January 13, 2026

Blip Or Trend? FDA Guidance Fell Off Steeply In 2025

Related professionals

Judith L. O'Grady

Judy O’Grady, a partner in Troutman Pepper Locke’s Health Care + Life Sciences Industry Group, was quoted in the January 13, 2026 Law360 article, “Blip Or Trend? FDA Guidance Fell Off Steeply In 2025.”

  • “They have fewer people — far fewer people,” said Judith O’Grady, a partner at Troutman Pepper Locke LLP and leader of its FDA regulatory team. “Issuing guidance documents is one thing that can kind of take a back seat when other things, like reviewing applications, really can’t.”
  • The changes, she said, have made the agency less predictable.
  • …
  • Without guidance, “there’s more unpredictability, and certainly we’ve seen a lot of increased unpredictability with this FDA that’s concerning to everyone in the industry,” Troutman’s O’Grady said.
Insight Industries + Practices

This just in

See all insights

Sponsored Events

Tuck School of Business: 21st Annual Private Equity and Venture Capital Conference

February 12 – 13, 2026
The Hanover Inn
Two East Wheelock Street, Hanover, NH 03755

Speaking Engagements

Oceantic Network IPF26: Energy at Sea

February 10, 2026  |  4:30 PM – 5:20 PM ET
New York City

Speaking Engagements

Best Practices for AI Review and Production of Voluminous ESI

February 9, 2026  |  7:00 AM – 8:00 AM CT
The Ritz-Carlton, New Orleans
921 Canal Street, New Orleans, LA 70112

Sponsored Events

2026 AUTM Annual Meeting

February 8 – 11, 2026
Seattle, WA

See all insights